| 1 |
White NJ. Severe malaria. Malar J 2022;21:284. [PMID: 36203155 DOI: 10.1186/s12936-022-04301-8] [Reference Citation Analysis]
|
| 2 |
Baird JK. African Plasmodium vivax malaria improbably rare or benign. Trends Parasitol 2022:S1471-4922(22)00109-X. [PMID: 35667992 DOI: 10.1016/j.pt.2022.05.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 3 |
Goo Y. Vivax Malaria and the Potential Role of the Subtelomeric Multigene vir Superfamily. Microorganisms 2022;10:1083. [DOI: 10.3390/microorganisms10061083] [Reference Citation Analysis]
|
| 4 |
Douglas NM, Burkot TR, Price RN. Malaria eradication revisited. Int J Epidemiol 2022;51:382-92. [PMID: 34918106 DOI: 10.1093/ije/dyab259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Phyo AP, Dahal P, Mayxay M, Ashley EA. Clinical impact of vivax malaria: A collection review. PLoS Med 2022;19:e1003890. [PMID: 35041650 DOI: 10.1371/journal.pmed.1003890] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 6 |
Mahittikorn A, Masangkay FR, Kotepui KU, Mala W, Milanez GDJ, Wilairatana P, Kotepui M. Alteration of Platelet Count in Patients with Severe Non-Plasmodium falciparum Malaria: A Systematic Review and Meta-Analysis. Biology 2021;10:1275. [DOI: 10.3390/biology10121275] [Reference Citation Analysis]
|
| 7 |
Clark IA. How diseases caused by parasites allowed a wider understanding of disease in general: my encounters with parasitology in Australia and elsewhere over the last 50 years. Int J Parasitol 2021:S0020-7519(21)00298-8. [PMID: 34757090 DOI: 10.1016/j.ijpara.2021.10.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Anstey NM, Grigg MJ, Rajahram GS, Cooper DJ, William T, Kho S, Barber BE. Knowlesi malaria: Human risk factors, clinical spectrum, and pathophysiology. Adv Parasitol 2021;113:1-43. [PMID: 34620381 DOI: 10.1016/bs.apar.2021.08.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 9 |
Devine A, Battle KE, Meagher N, Howes RE, Dini S, Gething PW, Simpson JA, Price RN, Lubell Y. Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study. PLoS Med 2021;18:e1003614. [PMID: 34061843 DOI: 10.1371/journal.pmed.1003614] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 10 |
Barber BE, Grigg MJ, Piera KA, Chen Y, William T, Weinberg JB, Yeo TW, Anstey NM. Endothelial glycocalyx degradation and disease severity in Plasmodium vivax and Plasmodium knowlesi malaria. Sci Rep 2021;11:9741. [PMID: 33963210 DOI: 10.1038/s41598-021-88962-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 11 |
Kho S, Qotrunnada L, Leonardo L, Andries B, Wardani PAI, Fricot A, Henry B, Hardy D, Margyaningsih NI, Apriyanti D, Puspitasari AM, Prayoga P, Trianty L, Kenangalem E, Chretien F, Brousse V, Safeukui I, Del Portillo HA, Fernandez-Becerra C, Meibalan E, Marti M, Price RN, Woodberry T, Ndour PA, Russell BM, Yeo TW, Minigo G, Noviyanti R, Poespoprodjo JR, Siregar NC, Buffet PA, Anstey NM. Evaluation of splenic accumulation and colocalization of immature reticulocytes and Plasmodium vivax in asymptomatic malaria: A prospective human splenectomy study. PLoS Med 2021;18:e1003632. [PMID: 34038413 DOI: 10.1371/journal.pmed.1003632] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 23.0] [Reference Citation Analysis]
|
| 12 |
Kojom Foko LP, Arya A, Sharma A, Singh V. Epidemiology and clinical outcomes of severe Plasmodium vivax malaria in India. J Infect 2021;82:231-46. [PMID: 33831459 DOI: 10.1016/j.jinf.2021.03.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 13 |
Santos MLS, Coimbra RS, Sousa TN, Guimarães LFF, Gomes MS, Amaral LR, Pereira DB, Fontes CJF, Hawwari I, Franklin BS, Carvalho LH. The Interface Between Inflammatory Mediators and MicroRNAs in Plasmodium vivax Severe Thrombocytopenia. Front Cell Infect Microbiol 2021;11:631333. [PMID: 33791239 DOI: 10.3389/fcimb.2021.631333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 14 |
Popovici J, Tebben K, Witkowski B, Serre D. Primaquine for Plasmodium vivax radical cure: What we do not know and why it matters. Int J Parasitol Drugs Drug Resist 2021;15:36-42. [PMID: 33529838 DOI: 10.1016/j.ijpddr.2020.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 15 |
Del-Tejo PL, Cubas-Vega N, Caraballo-Guerra C, da Silva BM, da Silva Valente J, Sampaio VS, Baia-da-Silva DC, Castro DB, Martinez-Espinosa FE, Siqueira AM, Lacerda MVG, Monteiro WM, Val F. Should we care about Plasmodium vivax and HIV co-infection? A systematic review and a cases series from the Brazilian Amazon. Malar J 2021;20:13. [PMID: 33407474 DOI: 10.1186/s12936-020-03518-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 16 |
Thriemer K, Poespoprodjo JR, Kenangalem E, Douglas NM, Sugiarto P, Anstey NM, Simpson JA, Price RN. The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia. PLoS Negl Trop Dis 2020;14:e0008838. [PMID: 33175835 DOI: 10.1371/journal.pntd.0008838] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 17 |
Penman BS, Gandon S. Adaptive immunity selects against malaria infection blocking mutations. PLoS Comput Biol 2020;16:e1008181. [PMID: 33031369 DOI: 10.1371/journal.pcbi.1008181] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 18 |
Rodrigo C, Rajapakse S, Fernando D. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria. Cochrane Database Syst Rev 2020;9:CD010458. [PMID: 32892362 DOI: 10.1002/14651858.CD010458.pub3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 19 |
Santos MLS, Coimbra RS, Sousa TN, Guimarães LFF, Gomes MS, Amaral LR, Pereira DB, Fontes CJF, Hawwari I, Franklin BS, Carvalho LH. A distinct fingerprint of inflammatory mediators and miRNAs in Plasmodium vivax severe thrombocytopenia.. [DOI: 10.1101/2020.08.20.260463] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 20 |
Milligan R, Daher A, Villanueva G, Bergman H, Graves PM. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax. Cochrane Database Syst Rev 2020;8:CD012656. [PMID: 32816320 DOI: 10.1002/14651858.CD012656.pub3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Price RN, Commons RJ, Battle KE, Thriemer K, Mendis K. Plasmodium vivax in the Era of the Shrinking P. falciparum Map. Trends Parasitol 2020;36:560-70. [PMID: 32407682 DOI: 10.1016/j.pt.2020.03.009] [Cited by in Crossref: 82] [Cited by in F6Publishing: 79] [Article Influence: 27.3] [Reference Citation Analysis]
|
| 22 |
Wångdahl A, Wyss K, Saduddin D, Bottai M, Ydring E, Vikerfors T, Färnert A. Severity of Plasmodium falciparum and Non-falciparum Malaria in Travelers and Migrants: A Nationwide Observational Study Over 2 Decades in Sweden. J Infect Dis 2019;220:1335-45. [PMID: 31175365 DOI: 10.1093/infdis/jiz292] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 23 |
Taylor WRJ, Kheng S, Muth S, Tor P, Kim S, Bjorge S, Topps N, Kosal K, Sothea K, Souy P, Char CM, Vanna C, Ly P, Khieu V, Christophel E, Kerleguer A, Pantaleo A, Mukaka M, Menard D, Baird JK. Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency. J Infect Dis 2019;220:1750-60. [PMID: 31549159 DOI: 10.1093/infdis/jiz313] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 24 |
Barber BE, Grigg MJ, Piera K, Amante FH, William T, Boyle MJ, Minigo G, Dondorp AM, McCarthy JS, Anstey NM. Antiphosphatidylserine Immunoglobulin M and Immunoglobulin G Antibodies Are Higher in Vivax Than Falciparum Malaria, and Associated With Early Anemia in Both Species. J Infect Dis 2019;220:1435-43. [PMID: 31250022 DOI: 10.1093/infdis/jiz334] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 25 |
Popovici J, Roesch C, Rougeron V. The enigmatic mechanisms by which Plasmodium vivax infects Duffy-negative individuals. PLoS Pathog 2020;16:e1008258. [PMID: 32078643 DOI: 10.1371/journal.ppat.1008258] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 26 |
Dini S, Douglas NM, Poespoprodjo JR, Kenangalem E, Sugiarto P, Plumb ID, Price RN, Simpson JA. The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study. BMC Med 2020;18:28. [PMID: 32075649 DOI: 10.1186/s12916-020-1497-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 27 |
Popovici J, Pierce-Friedrich L, Kim S, Bin S, Run V, Lek D, Hee KHD, Lee Soon-U L, Cannon MV, Serre D, Menard D. Recrudescence, Reinfection, or Relapse? A More Rigorous Framework to Assess Chloroquine Efficacy for Plasmodium vivax Malaria. J Infect Dis 2019;219:315-22. [PMID: 30102351 DOI: 10.1093/infdis/jiy484] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 28 |
Patriani D, Arguni E, Kenangalem E, Dini S, Sugiarto P, Hasanuddin A, Lampah DA, Douglas NM, Anstey NM, Simpson JA, Price RN, Poespoprodjo JR. Early and late mortality after malaria in young children in Papua, Indonesia. BMC Infect Dis 2019;19:922. [PMID: 31666012 DOI: 10.1186/s12879-019-4497-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 29 |
Milligan R, Daher A, Graves PM. Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria. Cochrane Database Syst Rev 2019;7:CD012656. [PMID: 31274189 DOI: 10.1002/14651858.CD012656.pub2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 30 |
Kenangalem E, Poespoprodjo JR, Douglas NM, Burdam FH, Gdeumana K, Chalfein F, Prayoga, Thio F, Devine A, Marfurt J, Waramori G, Yeung S, Noviyanti R, Penttinen P, Bangs MJ, Sugiarto P, Simpson JA, Soenarto Y, Anstey NM, Price RN. Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study. PLoS Med 2019;16:e1002815. [PMID: 31167228 DOI: 10.1371/journal.pmed.1002815] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 31 |
Setyadi A, Arguni E, Kenangalem E, Hasanuddin A, Lampah DA, Thriemer K, Anstey NM, Sugiarto P, Simpson JA, Price RN, Douglas NM, Poespoprodjo JR. Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia. Malar J 2019;18:111. [PMID: 30940140 DOI: 10.1186/s12936-019-2745-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 32 |
Gunalan K, Sá JM, Moraes Barros RR, Anzick SL, Caleon RL, Mershon JP, Kanakabandi K, Paneru M, Virtaneva K, Martens C, Barnwell JW, Ribeiro JM, Miller LH. Transcriptome profiling of Plasmodium vivax in Saimiri monkeys identifies potential ligands for invasion. Proc Natl Acad Sci U S A 2019;116:7053-61. [PMID: 30872477 DOI: 10.1073/pnas.1818485116] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 33 |
Kho S, Andries B, Poespoprodjo JR, Commons RJ, Shanti PAI, Kenangalem E, Douglas NM, Simpson JA, Sugiarto P, Anstey NM, Price RN. High Risk of Plasmodium vivax Malaria Following Splenectomy in Papua, Indonesia. Clin Infect Dis 2019;68:51-60. [PMID: 29771281 DOI: 10.1093/cid/ciy403] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 34 |
Commons RJ, Simpson JA, Thriemer K, Hossain MS, Douglas NM, Humphreys GS, Sibley CH, Guerin PJ, Price RN. Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis. Lancet Infect Dis 2019;19:91-101. [PMID: 30587297 DOI: 10.1016/S1473-3099(18)30596-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 35 |
Oyong DA, Kenangalem E, Poespoprodjo JR, Beeson JG, Anstey NM, Price RN, Boyle MJ. Loss of complement regulatory proteins on uninfected erythrocytes in vivax and falciparum malaria anemia. JCI Insight 2018;3:124854. [PMID: 30429373 DOI: 10.1172/jci.insight.124854] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 36 |
Gogoi D, Biswas D, Borkakoty B, Mahanta J. Exposure to Plasmodium vivax is associated with the increased expression of exhaustion markers on γδ T lymphocytes. Parasite Immunol 2018;40:e12594. [PMID: 30276843 DOI: 10.1111/pim.12594] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 37 |
Kondrashin AV, Morozova LF, Stepanova EV, Turbabina NA, Maksimova MS, Morozov EN. On the epidemiology of Plasmodium vivax malaria: past and present with special reference to the former USSR. Malar J 2018;17:346. [PMID: 30286752 DOI: 10.1186/s12936-018-2495-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 38 |
White MT, Walker P, Karl S, Hetzel MW, Freeman T, Waltmann A, Laman M, Robinson LJ, Ghani A, Mueller I. Mathematical modelling of the impact of expanding levels of malaria control interventions on Plasmodium vivax. Nat Commun 2018;9:3300. [PMID: 30120250 DOI: 10.1038/s41467-018-05860-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 39 |
Ashley EA, Pyae Phyo A, Woodrow CJ. Malaria. Lancet 2018;391:1608-21. [PMID: 29631781 DOI: 10.1016/S0140-6736(18)30324-6] [Cited by in Crossref: 295] [Cited by in F6Publishing: 211] [Article Influence: 59.0] [Reference Citation Analysis]
|
| 40 |
Gunalan K, Niangaly A, Thera MA, Doumbo OK, Miller LH. Plasmodium vivax Infections of Duffy-Negative Erythrocytes: Historically Undetected or a Recent Adaptation? Trends Parasitol 2018;34:420-9. [PMID: 29530446 DOI: 10.1016/j.pt.2018.02.006] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 11.4] [Reference Citation Analysis]
|
| 41 |
Baird JK. Tafenoquine for travelers' malaria: evidence, rationale and recommendations. J Travel Med 2018;25. [PMID: 30380095 DOI: 10.1093/jtm/tay110] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 42 |
Ley B, Thriemer K, Jaswal J, Poirot E, Alam MS, Phru CS, Khan WA, Dysoley L, Qi G, Kheong CC, Shamsudin UK, Chen I, Hwang J, Gosling R, Price RN. Barriers to routine G6PD testing prior to treatment with primaquine. Malar J 2017;16:329. [PMID: 28797255 DOI: 10.1186/s12936-017-1981-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 43 |
Niangaly A, Karthigayan Gunalan, Amed Ouattara, Coulibaly D, Sá JM, Adams M, Travassos MA, Ferrero J, Laurens MB, Kone AK, Thera MA, Plowe CV, Miller LH, Doumbo OK. Plasmodium vivax Infections over 3 Years in Duffy Blood Group Negative Malians in Bandiagara, Mali. Am J Trop Med Hyg 2017;97:744-52. [PMID: 28749772 DOI: 10.4269/ajtmh.17-0254] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 44 |
Val F, Machado K, Barbosa L, Salinas JL, Siqueira AM, Costa Alecrim MG, Portillo HD, Bassat Q, Monteiro WM, Guimarães Lacerda MV. Respiratory Complications of Plasmodium vivax Malaria: Systematic Review and Meta-Analysis. Am J Trop Med Hyg 2017;97:733-43. [PMID: 28722625 DOI: 10.4269/ajtmh.17-0131] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 45 |
Devine A, Parmiter M, Chu CS, Bancone G, Nosten F, Price RN, Lubell Y, Yeung S. Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis. PLoS Negl Trop Dis 2017;11:e0005602. [PMID: 28542194 DOI: 10.1371/journal.pntd.0005602] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 46 |
Milligan R, Daher A, Graves PM; Cochrane Infectious Diseases Group. Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd012656] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 47 |
Abreha T, Hwang J, Thriemer K, Tadesse Y, Girma S, Melaku Z, Assef A, Kassa M, Chatfield MD, Landman KZ, Chenet SM, Lucchi NW, Udhayakumar V, Zhou Z, Shi YP, Kachur SP, Jima D, Kebede A, Solomon H, Mekasha A, Alemayehu BH, Malone JL, Dissanayake G, Teka H, Auburn S, von Seidlein L, Price RN. Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial. PLoS Med 2017;14:e1002299. [PMID: 28510573 DOI: 10.1371/journal.pmed.1002299] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 48 |
Commons RJ, Thriemer K, Humphreys G, Suay I, Sibley CH, Guerin PJ, Price RN. The Vivax Surveyor: Online mapping database for Plasmodium vivax clinical trials. Int J Parasitol Drugs Drug Resist 2017;7:181-90. [PMID: 28384505 DOI: 10.1016/j.ijpddr.2017.03.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 49 |
Roche B, Rougeron V, Quintana-murci L, Renaud F, Abbate JL, Prugnolle F. Might Interspecific Interactions between Pathogens Drive Host Evolution? The Case of Plasmodium Species and Duffy-Negativity in Human Populations. Trends in Parasitology 2017;33:21-9. [DOI: 10.1016/j.pt.2016.09.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 50 |
Siqueira AM, Alencar AC, Melo GC, Magalhaes BL, Machado K, Alencar Filho AC, Kuehn A, Marques MM, Manso MC, Felger I, Vieira JL, Lameyre V, Daniel-Ribeiro CT, Lacerda MV. Fixed-Dose Artesunate-Amodiaquine Combination vs Chloroquine for Treatment of Uncomplicated Blood Stage P. vivax Infection in the Brazilian Amazon: An Open-Label Randomized, Controlled Trial. Clin Infect Dis 2017;64:166-74. [PMID: 27988484 DOI: 10.1093/cid/ciw706] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 51 |
Rajahram GS, Barber BE, William T, Grigg MJ, Menon J, Yeo TW, Anstey NM. Falling Plasmodium knowlesi Malaria Death Rate among Adults despite Rising Incidence, Sabah, Malaysia, 2010-2014. Emerg Infect Dis 2016;22:41-8. [PMID: 26690736 DOI: 10.3201/eid2201.151305] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 52 |
Howes RE, Battle KE, Mendis KN, Smith DL, Cibulskis RE, Baird JK, Hay SI. Global Epidemiology of Plasmodium vivax. Am J Trop Med Hyg 2016;95:15-34. [PMID: 27402513 DOI: 10.4269/ajtmh.16-0141] [Cited by in Crossref: 228] [Cited by in F6Publishing: 237] [Article Influence: 32.6] [Reference Citation Analysis]
|
| 53 |
Kenangalem E, Karyana M, Burdarm L, Yeung S, Simpson JA, Tjitra E, Anstey NM, Poespoprodjo JR, Price RN, Douglas NM. Plasmodium vivax infection: a major determinant of severe anaemia in infancy. Malar J 2016;15:321. [PMID: 27306221 DOI: 10.1186/s12936-016-1373-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 54 |
Quispe AM, Llanos-Cuentas A, Rodriguez H, Clendenes M, Cabezas C, Leon LM, Chuquiyauri R, Moreno M, Kaslow DC, Grogl M, Herrera S, Magill AJ, Kosek M, Vinetz JM, Lescano AG, Gotuzzo E. Accelerating to Zero: Strategies to Eliminate Malaria in the Peruvian Amazon. Am J Trop Med Hyg 2016;94:1200-7. [PMID: 30851016 DOI: 10.4269/ajtmh.15-0369] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 55 |
Gunalan K, Lo E, Hostetler JB, Yewhalaw D, Mu J, Neafsey DE, Yan G, Miller LH. Role of Plasmodium vivax Duffy-binding protein 1 in invasion of Duffy-null Africans. Proc Natl Acad Sci U S A 2016;113:6271-6. [PMID: 27190089 DOI: 10.1073/pnas.1606113113] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 56 |
Hanandita W, Tampubolon G. Geography and social distribution of malaria in Indonesian Papua: a cross-sectional study. Int J Health Geogr 2016;15:13. [PMID: 27072128 DOI: 10.1186/s12942-016-0043-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 57 |
St Laurent B, Supratman S, Asih PB, Bretz D, Mueller J, Miller HC, Baharuddin A, Shinta, Surya A, Ngai M, Laihad F, Syafruddin D, Hawley WA, Collins FH, Lobo NF. Behaviour and molecular identification of Anopheles malaria vectors in Jayapura district, Papua province, Indonesia. Malar J 2016;15:192. [PMID: 27060058 DOI: 10.1186/s12936-016-1234-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 58 |
Baird K. Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria. Pathog Glob Health 2015;109:93-106. [PMID: 25943156 DOI: 10.1179/2047773215Y.0000000016] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 59 |
Bennett JW, Yadava A, Tosh D, Sattabongkot J, Komisar J, Ware LA, McCarthy WF, Cowden JJ, Regules J, Spring MD, Paolino K, Hartzell JD, Cummings JF, Richie TL, Lumsden J, Kamau E, Murphy J, Lee C, Parekh F, Birkett A, Cohen J, Ballou WR, Polhemus ME, Vanloubbeeck YF, Vekemans J, Ockenhouse CF. Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy. PLoS Negl Trop Dis 2016;10:e0004423. [PMID: 26919472 DOI: 10.1371/journal.pntd.0004423] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 9.9] [Reference Citation Analysis]
|
| 60 |
Antinori S, Corona A, Ridolfo AL, Galimberti L, Ricaboni D, Milazzo L, Corbellino M. Imported Plasmodium vivax malaria with severe thrombocytopaenia: can it be severe malaria or not? Malar J 2016;15:105. [PMID: 26893220 DOI: 10.1186/s12936-016-1150-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 61 |
Robinson LJ, Laman M, Wini L, Mueller I. Plasmodium vivax in Oceania. Neglected Tropical Diseases 2016. [DOI: 10.1007/978-3-319-43148-2_6] [Reference Citation Analysis]
|
| 62 |
Vivax Working Group. Targeting vivax malaria in the Asia Pacific: The Asia Pacific Malaria Elimination Network Vivax Working Group. Malar J 2015;14:484. [PMID: 26627892 DOI: 10.1186/s12936-015-0958-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 63 |
de Souza AM, de Araújo FC, Fontes CJ, Carvalho LH, de Brito CF, de Sousa TN. Multiple-clone infections of Plasmodium vivax: definition of a panel of markers for molecular epidemiology. Malar J 2015;14:330. [PMID: 26303668 DOI: 10.1186/s12936-015-0846-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 64 |
Kibria MG, Elahi R, Mohon AN, Khan WA, Haque R, Alam MS. Genetic diversity of Plasmodium vivax in clinical isolates from Bangladesh. Malar J 2015;14:267. [PMID: 26159168 DOI: 10.1186/s12936-015-0790-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 65 |
Barber BE, William T, Grigg MJ, Parameswaran U, Piera KA, Price RN, Yeo TW, Anstey NM. Parasite biomass-related inflammation, endothelial activation, microvascular dysfunction and disease severity in vivax malaria. PLoS Pathog 2015;11:e1004558. [PMID: 25569250 DOI: 10.1371/journal.ppat.1004558] [Cited by in Crossref: 104] [Cited by in F6Publishing: 108] [Article Influence: 13.0] [Reference Citation Analysis]
|
